Drug-Loaded Microbubbles Can Diagnose, Treat Thrombosis

Share this content:
Drug-Loaded Microbubbles Can Diagnose, Treat Thrombosis
Drug-Loaded Microbubbles Can Diagnose, Treat Thrombosis

(HealthDay News) -- Targeted theranostic microbubbles (TT-MB), that consist of a fusion construct combining urokinase, echo-enhancing microbubbles for visualization by ultrasonography, and an activated platelet-specific single-chain antibody for specific targeting to thrombi, can diagnose and treat thrombosis. The findings were presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease 2015 Scientific Sessions, held from May 7 to 9 in San Francisco.

Xiaowei Wang, Ph.D., from the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, and colleagues hypothesized that thrombolytic drug-loaded MBs, which are selectively targeted to activated platelets, will allow high-resolution, real-time imaging of thrombosis. Experiments were conducted in the ferric chloride-induced carotid artery thrombosis mouse model.

The researchers found that treatment with TT-MB significantly reduced thrombus size after 45 minutes, while no significant difference was seen in the targeted MB without urokinase (37.09 versus 97.14 mean percent change, normalized to baseline thrombus size; P < 0.001). Efficient thrombolysis was only achievable to the same degree using a high dose of urokinase. The targeting and clot-enrichment effect of TT-MB resulted in a highly-potent fibrinolysis that could be only matched using high doses of non-targeted urokinase, but this was associated with a highly prolonged bleeding time (P < 0.001). TT-MB did not prolong bleeding time.

"This unique technology holds promise for major progress towards rapid diagnosis and bleeding-free, potent therapy of the vast number of patients suffering from thrombotic diseases," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve ...

Diagnostic error is the most common cause of medical errors that patients report

HbA1c Variability Is a Strong Predictor of Mortality in T2DM

HbA1c Variability Is a Strong Predictor of Mortality ...

HbA1c variability is a powerful, independent measure, regardless of how it is measured

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Actual probability of death for patients on liver transplant wait list underestimated by up to 17%

is free, fast, and customized just for you!




Already a member?

Sign In Now »